By: Jeffrey P. Krall, OD; Jaclyn A. Munson, OD, FAAO; and Carol B. Nelson, MD
This course has expired. You can still review the content but course credit is no longer available.
Trigeminal dysphoria is a term that describes a variety of symptoms including headaches, eyestrain, dry eye sensation, neck, and shoulder pain. New research suggests that computer vision syndrome, also called digital eye strain, is a form of visually induced trigeminal dysphoria. Clinicians who treat patients with these symptoms must be aware and understand why patients with trigeminal dysphoria are symptomatic and how to treat it.
This activity is supported by an unrestricted educational grant from eyeBrain Medical Inc.
Upon completion of this activity, the participant should be able to:
• Describe the optical neurological mechanism triggering headaches and how it relates to neck pain/tension and eye fatigue
• Explain how trigeminal dysphoria is a condition resulting from a misalignment in the visual system that causes stimulation of the trigeminal nerve, triggering patient symptoms
• Identify insights into how to identify and treat patients suffering from a misalignment in their vision
ACCREDITATION
Evolve is an approved COPE Administrator.
This course is COPE approved for 1.0 hours of CE credit for optometrists.
COPE Course ID: 63350-NO
COPE Activity ID: 117763
TO OBTAIN CREDIT
To obtain credit for this activity, you must read the activity in its entirety and complete the Posttest/Activity Evaluation/Satisfaction Measures Form, which consists of a series of multiple choice questions. Upon completing the activity and self-assessment test, you may print a CE Credit letter awarding 1 COPE Credit.
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.
The following faculty/staff members have the following financial relationships with commercial interests:
Jeffrey P. Krall, OD, and/or spouse has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: eyeBrain Medical.
Jaclyn A. Munson, OD, FAAO, and/or spouse has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board: Blephex, eyeBrain Medical; Colorado Dry Eye Society, and Oasis Medical.
Carol B. Nelson, MD, and/or spouse has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Stock/Shareholder: eyeBrain Medical.
EDITORIAL SUPPORT DISCLOSURES
Erin K. Fletcher, MIT, director of compliance and education, and Cassandra Richards, director of education development, Evolve, have no financial relationships with commercial interests. Jaya Kumar, MD, peer reviewer, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan and Novartis.
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, Modern Optometry, or eyeBrain Medical.
